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Guided Percutaneous Intervention
for a Mitral Valve Leaﬂet Perforation
Rajiv Goswami, DO, Barker Colin, MD, Matthew Jackson, MSC, Neal Kleiman, MD, Stephen Little, MDA 67-year-old woman with coronary arterydisease, peripheral vascular disease, andend-stage renal disease on hemodialysis pre-
sented with refractory decompensated congestive
heart failure. Echocardiography showed severe mitral
regurgitation from 2 sources: poor leaﬂet coaptation
due to tethering of the posterior leaﬂet and a per-
foration at the base of the posterior leaﬂet (Figure 2).
Cardiothoracic surgery declined to perform a surgical
valve replacement due to high operative risk.
We tested various devices in an explanted canine
mitral valve with a perforation created on the poste-
rior mitral leaﬂet to simulate the pathology in our
patient. The Amplatzer Duct Occluder II (St. Jude
Medical, St. Paul, Minnesota) appeared to seal theFIGURE 1 Ex Vivo Testing of the Amplatzer Duct Occluder II
Device (St. Jude Medical, St. Paul, Minnesota) in a Canine
Mitral Valve
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ence in leaﬂet and chordae function (Figure 1).
With the patient under general anesthesia and
3-dimensional transesophageal echocardiography
guidance (Figures 3 and 4), a guidewire was directed
across the perforation with the assistance of the Agilis
steerable introducer (St. Jude Medical), placed in the
left atrium through a transseptal puncture (Figure 4).
A 6  4-mm Amplatzer Duct Occluder II device was
deployed across the perforation (Figure 5). Left atrial
pressure measurements showed an acute reduction in
the V-wave from 60 to 40 mm Hg.
Repeat echocardiography showed a reduction in
total mitral regurgitation with complete seal of the
perforation by the device (Figure 6). Her left atrial
volume decreased from 84 ml to 67 ml, and left
ventricular function remained at 55%. She was
weaned off inotropes, discharged home and con-
tinues to make clinical progress.FIGURE 2 Severe Mitral Regurgitation Through the Posterior
Leaﬂet Perforation
See Online Video 1.
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FIGURE 5 A 3-Dimensional Transesophageal Echocardiography
Image of the Amplatzer Duct Occluder II (St. Jude Medical,
St. Paul, Minnesota) Deployed Across Perforation
The red arrow indicates the perforation. See Online Video 2.
FIGURE 4 Catheter Across the Posterior Leaﬂet Perforation
by 3-Dimensional Transesophageal Echocardiography
FIGURE 3 Systolic 3-Dimensional Transesophageal
Echocardiography Image of the Posterior Leaﬂet
Perforation (P3) Indicated by the Red Arrow
FIGURE 6 Signiﬁcant Reduction in Mitral Regurgitation With
the Device
See Online Video 3.
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APPENDIX For supplemental videos and their legends, please see
the online version of this article.
